Home › Chronic Myeloid Leukemia › Washington › Seattle

Pag-aaral pangklinika para sa Chronic Myeloid Leukemia sa Seattle, WA

Isang pag-aaral para sa Chronic Myeloid Leukemia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Seattle. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Swedish Medical Center-Ballard Campus, Seattle
Swedish Medical Center-Cherry Hill, Seattle
Swedish Medical Center-First Hill, Seattle
at 1 pa

Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

Study of Olverembatinib (HQP1351) in Patients With CML-CP

Nagre-recruitPhase 3

Ascentage Investigative Site #1806, Seattle
Ascentage Investigative Site #1510, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06423911

Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP

Nagre-recruitPhase 2

Seattle Childrens Hospital, Seattle

Edad 1 hanggang 18 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07354074

Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

Nagre-recruitPhase 2

Fred Hutch/University of Washington Cancer Consortium, Seattle

6 Months – 65 Years · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT06013423

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Nagre-recruitObservasyonal na pag-aaral

Fred Hutchinson Cancer Research Center, Seattle

Lahat ng edad · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT01351545

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo

Fred Hutch/University of Washington Cancer Consortium, Seattle

6 Months · Lahat ng kasarian · Na-update May 29, 2026 · NCT04195633

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Nagre-recruitPhase 1

Fred Hutch/University of Washington Cancer Consortium, Seattle

Hanggang edad 80 · Lahat ng kasarian · Na-update May 18, 2026 · NCT03326921

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Nagre-recruitPhase 2

Fred Hutchinson Cancer Center, Seattle

Edad 18 hanggang 66 · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT06859424

A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)

Nagre-recruitPhase 1/2

Fred Hutchinson Cancer Center, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 12, 2026 · NCT06163430

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

Nagre-recruitPhase 1

Fred Hutchinson Cancer Research Center, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2025 · NCT04260022

TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia

Nagre-recruitPhase 1

Fred Hutchinson Cancer Center, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 21, 2025 · NCT06088888

Pag-aaral para sa Chronic Myeloid Leukemia sa ibang lungsod

Iba pang pag-aaral sa Seattle

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.